Stroke
Conditions
Interventions
Control Group:According to the results of dysphagia screening, nutritional methods were selected: Grade II patients were recommended oral nutritional support (ONS), Grade III-IV patients considered th
Grade V patients had indwelling nasogastric tubes as per medical advice.
Intervention Group:For patients with dysphagia screening grade II-V, modified V-VST was evaluated. Level 1 (mild dysphagia), level 1-4 food can be swallowed safely
level 2 (mild dysphagia), eating level 2 and above food safety
level 3 (moderate dysphagia), eating level 3 and above food safety
Level 4 (severe dysphagia) can only safely eat level 4 food
Level 5 (severe dysphagia) It is not safe to eat level 1 to 4 food, and tube feeding nutrition is given as per medical advice.
Sponsors
The First Hospital of Jilin University
Eligibility
Sex/Gender
All
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: 1. Patients aged >= 18 years, regardless of gender; 2. Patients with ischemic stroke or hypertensive cerebral hemorrhage must meet the revised diagnostic criteria of the Fourth National Conference on Cerebrovascular Diseases and be confirmed by head CT or MRI; 3. Dysphagia screening grade II-V; 4. mRS <= 1 score before onset; 5. The patient was conscious and able to cooperate with the 30ml water swallowing test (WST) and e volume-viscosity swallow test (V-VST) assessment; 6. Patients or their immediate family members are able to understand and cooperate with the trial and are willing to sign informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients with dysphagia before admission; 2. Patients with significantly abnormal gastrointestinal function, frequentvomiting or diarrhea, or with enteral nutrition contraindications; 3. Patients who had combined with serious medical disease: severe liver or renal insufficiency; Severe hepatic insufficiency is characterized by ALT > 2 times the upper limit of normal or AST > 2 times the upper limit of normal. Severe renal insufficiency is defined as creatinine values greater than 1.5 times the upper limit of normal and CrCl<30ml/min; 4. Patients with tracheotomy, Any organic disease of the airway or esophagus; 5. Patients with history of surgery within the past 3 months; 6. Patients who had received enteral nutritional support before admission; 7. Pregnant or lactating women; 8. Patients with a life expectancy of less than 3 months or who are unable to complete the study for other reasons; 9. Patients with reluctance to follow up or poor treatment compliance; 10. Patients had participated in or concurrently participated in another clinical study within 4 weeks prior to screening; 11. Patients with dairy allergy history; 12. Other conditions deemed unsuitable for inclusion by the researcher.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The total effective rates of swallowing function improved; | — |
Secondary
| Measure | Time frame |
|---|---|
| Prognostic Nutritional Index (PNI);Micronutrient Assessment Form (MNA-SF) score;Nutritional intake up to standard rate;Modified Rankin Scale (mRS);Functional Independence Measure, FIM;The average time of nasal feeding tube insertion during hospitalization;Rate of nasal feeding tube at discharge;Average length of stay; | — |
Countries
China
Contacts
Public ContactYan Xiuli
The First Hospital of Jilin University
Outcome results
None listed